Emerging Epidemics are mentioned directly in the overall objectives of the HEALTH theme in the Specific Programme "Cooperation"1 :
"Improving the health of European citizens and increasing the competitiveness and boosting the innovative capacity of European health-related industries and businesses, while addressing global health issues including emerging epidemics. Emphasis will be put on translational research (translation of basic discoveries in clinical applications including scientific validation of experimental results), the development and validation of new therapies, methods for health promotion and prevention including promotion of child health, healthy ageing, diagnostic tools and medical technologies, as well as sustainable and efficient health care systems."
The more detailed description of this area in the same document states:
"Potentially new and re-emerging epidemics: the focus will be on confronting emerging pathogens with pandemic potential including zoonoses (e.g. SARS and highly pathogenic influenza). Where appropriate, provisions will be made for rapidly initiating collaborative research aimed at expediting development of new diagnostics, drugs and vaccines for efficient prevention, treatment, and control of infectious disease emergencies."
Our intention is to cover the entire "value chain" of health research from basic virology to translational and clinical research all the way to public health aspects of these diseases (the latter topics might be offered in this area as well as in the specific Public Health pillar of the programme).